NFKB1 and glioblastoma: Ketamine reduces NFkB activation in A172 human glioblastoma cells exposed to LPS (Sakai et al., 2000) and reduces TNFα and IL6 production by LPS-stimulated RAW 267.4 (transformed mouse macrophage) cells (Wu et al., 2008).